D. Burkitt, A sarcoma involving the jaws in african children, British Journal of Surgery, vol.46, issue.197, pp.218-223, 1958.

C. Casulo and J. W. Friedberg, Burkitt lymphoma- a rare but challenging lymphoma, Best Practice & Research Clinical Haematology, vol.31, issue.3, pp.279-284, 2018.

S. H. Swerdlow, E. Campo, S. A. Pileri, N. L. Harris, H. Stein et al., The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, issue.20, pp.2375-2390, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800015

P. C. Bishop, V. K. Rao, and W. H. Wilson, Burkitt's Lymphoma: Molecular Pathogenesis and Treatment, Cancer Investigation, vol.18, issue.6, pp.574-583, 2000.

V. Ribrag, S. Koscielny, J. Bosq, T. Leguay, O. Casasnovas et al., Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial, The Lancet, vol.387, issue.10036, pp.2402-2411, 2016.

E. S. Jaffe and . The, The 2008 WHO classification of lymphomas: implications for clinical practice and translational research, Hematology, vol.2009, issue.1, pp.523-531, 2009.

E. M. Molyneux, R. Rochford, B. Griffin, R. Newton, G. Jackson et al., Burkitt's lymphoma, The Lancet, vol.379, issue.9822, pp.1234-1244, 2012.

J. Orem, E. K. Mbidde, B. Lambert, S. De-sanjose, and E. Weiderpass, Burkitt's lymphoma in Africa, a review of the epidemiology and etiology, Afr Health Sci, vol.7, pp.166-75, 2007.

I. Magrath, Epidemiology: clues to the pathogenesis of Burkitt lymphoma, British Journal of Haematology, vol.156, issue.6, pp.744-756, 2012.

O. W. Mwanda, R. Rochford, A. M. Moormann, A. Macneil, C. Whalen et al., Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution, East African Medical Journal, vol.81, issue.8, pp.68-77, 2004.

M. Sant, C. Allemani, C. Tereanu, R. De-angelis, R. Capocaccia et al., Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project, Blood, vol.116, issue.19, pp.3724-3734, 2010.

S. M. Mbulaiteye, R. J. Biggar, K. Bhatia, M. S. Linet, and S. S. Devesa, Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005, Pediatric Blood & Cancer, vol.53, issue.3, pp.366-370, 2009.

J. O. Armitage and D. D. Weisenburger, New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project., Journal of Clinical Oncology, vol.16, issue.8, pp.2780-2795, 1998.

D. M. Knowles, Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma, Hematology/Oncology Clinics of North America, vol.17, issue.3, pp.785-820, 2003.

O. Martínez-maza and E. C. Breen, B-cell activation and lymphoma in patients with HIV, Current Opinion in Oncology, vol.14, issue.5, pp.528-532, 2002.

V. Beral, T. Peterman, R. Berkelman, and H. Jaffe, AIDS-associated non-Hodgkin lymphoma, The Lancet, vol.337, issue.8745, pp.805-809, 1991.

F. Davi, H. J. Delecluse, P. Guiet, J. Gabarre, A. Fayon et al., Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group., Journal of Clinical Oncology, vol.16, issue.12, pp.3788-3795, 1998.

M. Spina, U. Tirelli, V. Zagonel, A. Gloghini, R. Volpe et al., Burkitt's lymphoma in adults with and without human immunodeficiency virus infection, Cancer, vol.82, issue.4, pp.766-774, 1998.

M. Guech-ongey, E. P. Simard, W. F. Anderson, E. A. Engels, K. Bhatia et al., AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?, Blood, vol.116, issue.25, pp.5600-5604, 2010.

J. A. Ferry, Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis, The Oncologist, vol.11, issue.4, pp.375-383, 2006.

E. W. Massey, J. Moore, and S. C. Schold, Mental neuropathy from systemic cancer, Neurology, vol.31, issue.10, pp.1277-1277, 1981.

K. A. Blum, G. Lozanski, and J. C. Byrd, Adult Burkitt leukemia and lymphoma, Blood, vol.104, issue.10, pp.3009-3020, 2004.

I. T. Magrath, African Burkitt?s Lymphoma, Journal of Pediatric Hematology/Oncology, vol.13, issue.2, pp.222-246, 1991.

B. Falini, M. Fizzotti, S. Pileri, A. Liso, L. Pasqualucci et al., Bcl-6 protein expression in normal and neoplastic lymphoid tissue, Annals of Oncology, vol.8, pp.S101-S104, 1997.

C. Casulo and J. Friedberg, Treating Burkitt Lymphoma in Adults, Current Hematologic Malignancy Reports, vol.10, issue.3, pp.266-271, 2015.

K. Dunleavy, R. F. Little, and W. H. Wilson, Update on Burkitt Lymphoma, Hematology/Oncology Clinics of North America, vol.30, issue.6, pp.1333-1343, 2016.

S. B. Murphy, W. P. Bowman, M. Abromowitch, J. Mirro, J. Ochs et al., Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine., Journal of Clinical Oncology, vol.4, issue.12, pp.1732-1739, 1986.

C. Patte, T. Philip, C. Rodary, J. M. Zucker, H. Behrendt et al., High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children., Journal of Clinical Oncology, vol.9, issue.1, pp.123-132, 1991.

C. Patte, A. Auperin, J. Michon, H. Behrendt, G. Leverger et al., The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia, Blood, vol.97, issue.11, pp.3370-3379, 2001.

A. Reiter, M. Schrappe, M. Tiemann, R. Parwaresch, M. Zimmermann et al., Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies., Journal of Clinical Oncology, vol.12, issue.5, pp.899-908, 1994.

G. M. Mead, M. R. Sydes, J. Walewski, A. Grigg, C. S. Hatton et al., An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt?s lymphoma: results of United Kingdom Lymphoma Group LY06 study, Annals of Oncology, vol.13, issue.8, pp.1264-1274, 2002.

G. M. Mead, S. L. Barrans, W. Qian, J. Walewski, J. A. Radford et al., A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial), Blood, vol.112, issue.6, pp.2248-2260, 2008.

K. Dunleavy, S. Pittaluga, M. Shovlin, S. M. Steinberg, D. Cole et al., Low-Intensity Therapy in Adults with Burkitt's Lymphoma, New England Journal of Medicine, vol.369, issue.20, pp.1915-1925, 2013.

D. A. Thomas, S. Faderl, S. O'brien, C. Bueso-ramos, J. Cortes et al., Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia, Cancer, vol.106, issue.7, pp.1569-1580, 2006.

D. A. Thomas, J. Cortes, S. Faderl, S. O?brien, F. J. Giles et al., Hyper-CVAD and rituximab therapy in HIV-Negative Burkitt (BL) or Burkitt-like (BLL) leukemia/lymphoma and mature B-cell acute lymphocytic leukemia (B-ALL), Journal of Clinical Oncology, vol.23, issue.16_suppl, pp.6531-6531, 2005.

D. Hoelzer, J. Walewski, H. Döhner, A. Viardot, W. Hiddemann et al., Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial, Blood, vol.124, issue.26, pp.3870-3879, 2014.

M. Dozzo, F. Carobolante, P. M. Donisi, A. Scattolin, E. Maino et al., Burkitt lymphoma in adolescents and young adults: management challenges, Adolescent Health, Medicine and Therapeutics, vol.Volume 8, pp.11-29, 2016.

J. Cortes, D. Thomas, A. Rios, C. Koller, S. O'brien et al., Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related burkitt lymphoma/leukemia, Cancer, vol.94, issue.5, pp.1492-1499, 2002.

A. Noy, J. Y. Lee, E. Y. Cesarman, R. Ambinder, R. Baiocchi et al., AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma, Blood, vol.126, issue.2, pp.160-166, 2015.

G. W. Van-imhoff, B. Van-der-holt, M. A. Mackenzie, G. J. Ossenkoppele, P. W. Wijermans et al., Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma, Leukemia, vol.19, issue.6, pp.945-952, 2005.

K. W. Song, M. J. Barnett, R. D. Gascoyne, D. E. Horsman, D. L. Forrest et al., Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma*, British Journal of Haematology, vol.133, issue.6, pp.634-637, 2006.

J. W. Sweetenham, R. Pearce, G. Taghipour, D. Blaise, C. Gisselbrecht et al., Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation., Journal of Clinical Oncology, vol.14, issue.9, pp.2465-2472, 1996.

L. V. Maramattom, P. N. Hari, L. J. Burns, J. Carreras, W. Arcese et al., Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research, Biology of Blood and Marrow Transplantation, vol.19, issue.2, pp.173-179, 2013.

C. Patte, T. Philip, C. Rodary, A. Bernard, J. M. Zucker et al., Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society., Journal of Clinical Oncology, vol.4, issue.8, pp.1219-1226, 1986.

M. R. Schwenn, S. R. Blattner, E. Lynch, and H. J. Weinstein, HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia., Journal of Clinical Oncology, vol.9, issue.1, pp.133-138, 1991.

A. Reiter, M. Schrappe, R. Parwaresch, G. Henze, S. Müller-weihrich et al., Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group., Journal of Clinical Oncology, vol.13, issue.2, pp.359-372, 1995.

A. Atra, M. Gerrard, R. Hobson, J. D. Imeson, S. Ashley et al., Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL) - results of the UKCCSG 9003 protocol, British Journal of Cancer, vol.77, issue.12, pp.2281-2285, 1998.

M. S. Cairo, M. Gerrard, R. Sposto, A. Auperin, C. R. Pinkerton et al., Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents, Blood, vol.109, issue.7, pp.2736-2743, 2006.

S. Goldman, L. Smith, J. R. Anderson, S. Perkins, L. Harrison et al., Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children?s Oncology Group report, Leukemia, vol.27, issue.5, pp.1174-1177, 2012.

S. Goldman, L. Smith, P. Galardy, S. L. Perkins, J. K. Frazer et al., Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report, British Journal of Haematology, vol.167, issue.3, pp.394-401, 2014.

D. A. Thomas, J. Cortes, S. O'brien, S. Pierce, S. Faderl et al., Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia, Journal of Clinical Oncology, vol.17, issue.8, pp.2461-2461, 1999.

M. Diviné, P. Casassus, S. Koscielny, J. Bosq, C. Sebban et al., Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol, Annals of Oncology, vol.16, issue.12, pp.1928-1935, 2005.

J. Lund and C. Wright, Building Union Power Through the Supply Chain, Labor Studies Journal, vol.27, issue.4, pp.59-75, 2003.